Motivational Evaluation and Intervention With Co-Adapt Application for Healthy Ageing

Self Efficacy Clinical Trial

Official title:

Motivational Evaluation and Intervention With Co-Adapt Application for Healthy Ageing

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05116553
• Other study ID #: COADAPT 2021 T-6.4
• Status: Completed
• Phase: N/A
• Start date: November 11, 2021
• Est. completion date: January 20, 2022

Study information

• Verified date: January 2022
• Source: Idego srl
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of this study is to identify effective methodologies to help people to improve their awareness of change, motivation, self-confidence and self-efficacy, compliance in behavioral change and psychological well-being.

Description:

Subjects involved will have the opportunity to partecipate in a two-weeks course: two SDT (Self Determination Theory) psychological interviews are scheduled (1 per week) to help the participant increase his motivation and awareness about the problem reported during the counseling session. For this purpose, the use of an APP with a CA (Conversational Agent) will be implemented as a support to help people to identify one's thoughts and emotional states as well as increase their awareness about themselves. Test will be administered at the beginning (T1) and at the end of the meetings (T2). Participants will be randomly divided into one of two groups to understand whether APP and CA has a significant impact in increasing motivation and awareness of the need for a pathway with a professional.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 74
• Est. completion date: January 20, 2022
• Est. primary completion date: December 31, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 50 Years to 67 Years

Eligibility

Inclusion Criteria:

• whitecollar
• a sufficient level of education to understand study procedures and be able to communicate with site personnel
• 50 to 70 years old

Exclusion Criteria:

• current use of narcotics or other substances

Related Conditions & MeSH terms

• Motivation
• Self Efficacy

Intervention

Behavioral:
• SDT
Standard 2 SDT (Self Determination Theory) psychological interviews.

Device:
• APP + CA
An APP with a CA (Conversational Agent).

Locations

Country	Name	City	State
Italy	Idego srl	Rome

Sponsors (1)

Lead Sponsor	Collaborator
Idego srl

Country where clinical trial is conducted

Italy, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in levels of General Self-Efficacy Scale-10 (GSE-10)	GSE-10 test is a validated test for the detection of general self efficacy. The total score ranges from 10 to 40. Higher scores mean better outcomes.	Up to day 14
Primary	Change in levels of Basic Psychological Need Satisfaction and Frustration Scale (BPNSFS)	The BPNSFP-24 test is a validated test for the detection of the satisfaction and frustration of the primary needs: autonomy, relatedness and competence (according to SDT Theory). The total score ranges from 24 to 120. Higher scores mean better outcomes.	Up to day 14
Secondary	Change of the scales contained in the Depression Anxiety Stress Scales-21 (DASS-21)	The DASS-21 test is a validated test for the detection of depression, anxiety and stress. The total score of each subscale ranges from 0 to 42. Higher scores mean worse outcomes.	Up to day 14
Secondary	Change in World Health Organisation-Five Well-Being Index (WHO-5)	The WHO-5 test is a validated test for the detection of psychological wellbeing. The total score ranges from 0 to 100. Higher scores mean better outcomes.	Up to day 14